Valuation: Merck KGaA

Market Cap 63.67B 69.91B 58.67B 53.37B 100B 6,474B 105B 714B 284B 3,536B 262B 257B 11,097B P/E 2026 *
25.3x
P/E 2027 * 20.9x
Enterprise Value 70.98B 77.93B 65.4B 59.49B 112B 7,217B 117B 796B 316B 3,942B 292B 286B 12,370B EV / Sales 2026 *
3.27x
EV / Sales 2027 * 3.01x
Free-Float
29.73%
Yield 2026 *
1.6%
Yield 2027 * 1.64%
1 day-1.31%
1 week-2.11%
Current month-3.21%
1 month+0.03%
3 months+6.08%
6 months+19.31%
Current year+19.45%
1 week 145.7
Extreme 145.7
152.35
1 month 141.6
Extreme 141.6
156.25
Current year 100.7
Extreme 100.7
156.25
1 year 100.7
Extreme 100.7
156.25
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 61 2026-04-30
Director of Finance/CFO 56 2023-06-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2019-04-25
Director/Board Member 60 2014-05-08
Director/Board Member 50 2020-05-27
Date Insider Type Main position Quantity % Market Cap. Importance
3/25/26 Buy

Chief Executive Officer

3,386 0.0026%
3/25/26 Buy

Chief Financial Officer

4,563 0.0035%
3/27/25 Buy 1,401 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%-2.11%+32.41%-9.07% 69.91B
-0.30%-6.68%+29.12%+125.42% 1,200B
+1.25%-5.35%+33.19%+80.42% 651B
+0.94%-2.99%+24.73%+106.93% 506B
-0.60%-1.95%+27.26%+67.32% 377B
+0.69%-9.50%+40.80%+30.23% 330B
+0.41%-4.70%+27.23%+51.59% 288B
+0.81%-4.08%-1.74%+32.71% 272B
-0.15%-6.45%+29.63%+64.18% 236B
-0.06%-0.98%+33.15%+118.99% 206B
Average +0.20%-4.49%+27.58%+66.87% 414B
Weighted average by Cap. +0.37%-5.14%+28.11%+85.86%

Financials

2026 *2027 *
Net sales 21.72B 23.84B 20.01B 18.2B 34.15B 2,208B 35.89B 244B 96.8B 1,206B 89.46B 87.58B 3,785B 22.92B 25.17B 21.12B 19.21B 36.05B 2,331B 37.88B 257B 102B 1,273B 94.43B 92.44B 3,995B
Net income 2.35B 2.59B 2.17B 1.97B 3.7B 239B 3.89B 26.41B 10.5B 131B 9.7B 9.5B 410B 2.9B 3.19B 2.68B 2.43B 4.56B 295B 4.8B 32.56B 12.94B 161B 11.96B 11.71B 506B
Net Debt 7.31B 8.02B 6.73B 6.12B 11.49B 743B 12.08B 81.95B 32.57B 406B 30.1B 29.47B 1,274B 5.39B 5.92B 4.97B 4.52B 8.47B 548B 8.91B 60.43B 24.02B 299B 22.2B 21.73B 939B
Projected Income Statement - Annual - Merck KGaA
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
61,949
Date Price Change Volume
26-11-20 €146.45 -1.31% 361,524
26-11-19 €148.40 -0.74% 240,481
26-11-18 €149.50 -0.83% 366,217
26-11-17 €150.75 +0.70% 439,798
26-11-16 €149.70 +0.07% 258,209
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Merck KGaA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
146.45EUR
Average target price
160.00EUR
Spread / Average Target
+9.25%